SCHEMBL3349282

SCHEMBL3349282

COC[C@H](O)Cn1nccc(-c2ccc(C)c(C(N)=O)c2)c1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHUK O15111 4/20 0.34
MAPK8 P45983 4/20 0.34
CAMKK2 Q96RR4 4/20 0.34
INSR P06213 3/20 0.34
SYK P43405 1/20 0.33
P2RX7 Q99572 1/20 0.33
BTK Q06187 1/20 0.33
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
AVPR2 P30518 1/20 0.32
AVPR1A P37288 1/20 0.32
MKNK1 Q9BUB5 2/20 0.32
MKNK2 Q9HBH9 2/20 0.32
LMNA P02545 2/20 0.31
MITF O75030 1/20 0.31
S1PR4 O95977 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3349288 0.87 KDM4E (0.33) P2RX7ALDH1A1KDM4ETSHRLMNA
SCHEMBL6526034 0.81 RAB9A (0.41) CHUKMAPK8CAMKK2SYKP2RX7
SCHEMBL3344666 0.79 MEN1 (0.45) ALDH1A1KDM4ETSHRLMNAMAPT
SCHEMBL3343187 0.79 P2RX7 (0.47) CHUKMAPK8CAMKK2SYKP2RX7
SCHEMBL3348216 0.79 P2RX7 (0.44) SYKP2RX7ALDH1A1KDM4EHPGD
SCHEMBL3342874 0.79 P2RX7 (0.44) SYKP2RX7ALDH1A1KDM4EHPGD
SCHEMBL1226640 0.78 KMT2A (0.31) ROCK1
SCHEMBL1226731 0.78 KMT2A (0.31) ROCK1
SCHEMBL3342461 0.75 P2RX7 (0.43) CHUKSYKP2RX7BTKMKNK1
SCHEMBL3342512 0.71 USP30 (0.41) CHUKMAPK8CAMKK2SYKL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435990-B2 Dihydropyrimidone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-05-07 US disclosed
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS BROTHERTON-PLEISS CHRISTINE E 2011-02-03 US disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 CHUK 1510/4885MAPK8 2695/4885CAMKK2 2040/4885
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX7, P2RX3 CHUK 518/4885MAPK8 1816/4885CAMKK2 2171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.